LOS ANGELES,
CA–(Jan 9, 2017) – Vitality Biopharma, Inc. (OTCQB: VBIO)
(“Vitality Biopharma,” “Vitality,” or the “Company”) a corporation dedicated to
the development of cannabinoid prodrug pharmaceuticals, and to unlocking the
power of cannabinoids for the treatment of serious neurological and
inflammatory disorders, today announced that it will present at the Ninth
Annual Biotech Showcase 2017 Conference, on January 11, at the Hilton San
Francisco Union Square.
Company CEO Robert Brooke will
provide a 30-minute overview of Vitality Biopharma’s business during his
presentation and will be available to participate in one-on-one meetings with
registered attendees.
Event: Biotech Showcase Conference
Date: Wednesday, January 11, 2017
Time: 8:00 a.m. PT
Track: Room 8 (Ballroom Level)
Location: Hilton San Francisco Union Square, San
Francisco, CA
Investors and
other interested parties will be able to access a copy of the presentation by
visiting the investors section of the Vitality Biopharma website at http://vitality.bio/investors/presentation.
About Biotech Showcase 2017:
Biotech Showcase™ is an investor and partnering
conference devoted to providing private and public biotechnology and life
sciences companies with an opportunity to present to, and meet with, investors
and pharmaceutical executives in one place during the course of one of the
industry’s largest annual healthcare investor conferences.
Vitality
Biopharma is dedicated to unlocking the power of cannabinoids for the treatment
of serious neurological and inflammatory disorders. For more information,
visit: www.vitality.bio.
Follow us on Facebook, Twitter and LinkedIn.
Notice Regarding Forward-Looking Statements:
This news
release contains “forward-looking statements” as that term is defined in
Section 27(a) of the United States Securities Act of 1933, as amended and
Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in
this press release which are not purely historical are forward-looking
statements and include any statements regarding beliefs, plans, expectations or
intentions regarding the future. Such factors include, among others, the
inherent uncertainties associated with new projects and development stage
companies. These forward-looking statements are made as of the date of this
news release, and we assume no obligation to update the forward-looking
statements, or to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe that any
beliefs, plans, expectations and intentions contained in this press release are
reasonable, there can be no assurance that any such beliefs, plans,
expectations or intentions will prove to be accurate. Investors should consult
all of the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-K for the most
recent fiscal year, our quarterly reports on Form 10-Q and other periodic
reports filed from time-to-time with the Securities and Exchange Commission.
Resources: http://vitality.bio/2017/01/vitality-biopharma-present-biotech-showcase-2017/
0 comments:
Post a Comment